Dr. Zhang’s research focus is on identifying novel drug outcomes from real-world data. Notable recent accomplishments of the Zhang Lab are the identification of telmisartan as a repurposable drug for Alzheimer's disease in African Americans and identifying relationships involving adverse drug events, drug combinations, and COVID-19 vaccines.

AnalytiXIN has supported Dr. Zhang’s lab financially and has given him opportunities to promote his research and make connections through AnalytiXIN faculty focused convenings.